Welcome!

News Feed Item

Weightmasters Reveal Successful Results from Clinical Trials on Natural Appetite Suppressant, Opriimo

LONDON, January 23, 2014 /PRNewswire/ --

The recent BBC report on January 3rd revealed shocking figures of obesity quadrupling to nearly one billion in the developing world since the 1980s. 64% of adults are now classified as overweight or obese in the UK. With high levels of cheap convenience food available, and the increasing numbers of overweight Brits on the increase, Weightmasters have revealed successful results from clinical trials on their Natural Appetite Suppressant, Opriimo. (http://www.bbc.co.uk/news/health-25576400)

Opriimo is a revolutionary NEW weight management solution. It's a medical device and Natural Appetite Suppressant proven for weight management and the supportive treatment of excess weight. Unlike its closest comparable forms of Gastric Surgery, it's totally non-invasive, and available without hospital stay or prescription.

The effectiveness and tolerability of Opriimo has been investigated through three different clinical trials. All three were placebo-controlled, randomised, double-blind crossover studies. The clinical studies involved subjects, undergoing a series of methods over a 12 week period. The premise of these studies was to establish the ingredient, Alginate's effects towards weight reduction, satiation (appetite suppression) and the regulation of appetite.

Summarised results of Clinical Trials:

Alginate (a natural sponge, similar to seaweed), expands in the stomach. Radiological tests have demonstrated that the alginate solids remain in the stomach for up to 8 hours. (Krakamp et al 2000).

The sponges meet with the stomach wall and stimulate the receptors, which transmit a feeling of satiation (fullness), usually within 20-30 minutes of eating. (Schusdziarra 1996).

Where the capsules were taken 20-30 minutes before meals, excellent or favourable pre-satiation (fullness before eating) was achieved in 85 % of all participants during studies. (Willmen et al 1999).

Clinical Trial 1: The Investigation into the satiation effect of Alginate bodies. (Willmen 2002)

Undertaken to determine the satiation effect of Alginate bodies, 46 subjects were assessed where randomly selected subjects were given the Alginate (active group), while others given a placebo. The Results were significant in favour of the active group given Alginate. No clinically relevant side effects were observed.

Clinical Trial 2: The Investigation into significant weight reduction by stimulation of satiation sensors. (Willmen 2002)

Undertaken to determine the effectiveness of Alginate for weight loss and Satiation. 139 subjects took part in this investigation over 12 weeks. They took 3 x 3 capsules before main meals. Subjects given Alginate (active group) showed a more significant weight reduction (of up to 9.4Kg) compared to those taking the placebo. Additionally, satiation scores were significantly higher and fewer subjects dropped out of the trial from the active group.

Clinical Trial 3: Investigation into the regulation of appetite. (Willmen 2002)

Undertaken to determine the effectiveness of Alginate for the regulation of appetite. 25 subjects took part in this investigation. This was a mixed male / female group, aged between 18-70, all were normal weight. Randomly some subjects were given the Alginate capsules 3 x 3 per day (the active group), while others given a placebo. Subject groups were assessed regarding the calories consumed and saved. Results were statistically significant in favour of the active group. The calculation of the amount of food into calories showed that the participants consumed an average reduction of 158 less calories per day. Calculated on a yearly basis this calorie reduction equates to 57670 Kcal with a weight loss of 8Kg.

Additionally the reduction of appetite was 82.5 % in the active group, plus significantly less food was consumed and the appetite was lower. The differences between the groups were significant in favour of those taking Alginate (active group). No clinically relevant side effects were observed.

From the results of the three different clinical trials, the product has been proven as an effective Natural Appetite Suppressant for weight management and the supportive treatment of excess weight. It has been awarded CE product certification and approval from MHRA under EU Medical Device directives.

The results of the clinical trials have been summarised for ease of reading. The full clinical reports from the trials are available on request from [email protected]

About Opriimo:

Opriimo is a revolutionary new medical device designed to help people eat less, feel full and manage weight. It's totally non-invasive, so no surgery is required. There are no complicated diets to follow, and it is clinically proven.

Opriimo also comes with full 1:1 support from a personal weight management consultant.

  • Certified Medical Device
  • Clinically Proven
  • Non Invasive (No Surgery Required)
  • No Complicated Diets to follow
  • Includes 1:1 support from your own personal weight management consultant

Because of the nature of the product, Opriimo is not suitable for all, and some qualification criteria apply.

For more details, contact Weightmasters on +44(0)208-619-0025 or email [email protected].

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
It is ironic, but perhaps not unexpected, that many organizations who want the benefits of using an Agile approach to deliver software use a waterfall approach to adopting Agile practices: they form plans, they set milestones, and they measure progress by how many teams they have engaged. Old habits die hard, but like most waterfall software projects, most waterfall-style Agile adoption efforts fail to produce the results desired. The problem is that to get the results they want, they have to ch...
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Loom is applying artificial intelligence and machine learning into the entire log analysis process, from start to finish and at the end you will get a human touch,” explained Sabo Taylor Diab, Vice President, Marketing at Loom Systems, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
When growing capacity and power in the data center, the architectural trade-offs between server scale-up vs. scale-out continue to be debated. Both approaches are valid: scale-out adds multiple, smaller servers running in a distributed computing model, while scale-up adds fewer, more powerful servers that are capable of running larger workloads. It’s worth noting that there are additional, unique advantages that scale-up architectures offer. One big advantage is large memory and compute capacity...
We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
The Internet giants are fully embracing AI. All the services they offer to their customers are aimed at drawing a map of the world with the data they get. The AIs from these companies are used to build disruptive approaches that cannot be used by established enterprises, which are threatened by these disruptions. However, most leaders underestimate the effect this will have on their businesses. In his session at 21st Cloud Expo, Rene Buest, Director Market Research & Technology Evangelism at Ara...
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), provided an overview of various initiatives to certify the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldwide re...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
"We are a monitoring company. We work with Salesforce, BBC, and quite a few other big logos. We basically provide monitoring for them, structure for their cloud services and we fit into the DevOps world" explained David Gildeh, Co-founder and CEO of Outlyer, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...